Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pertuzumab to bolster Roche/Genentech's breast cancer franchise?

× No keyword cloud information.

5 in total

Review 1. Protein therapeutics: new applications for pharmacogenetics.

Authors: Cecile Krejsa; Mark Rogge; Wolfgang Sadee
Journal: Nat Rev Drug Discov Date: 2006-06 Impact factor: 84.694

2. Pushing the envelope.

Authors:
Journal: Nat Biotechnol Date: 2011-08-05 Impact factor: 54.908

3. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Authors: D J Slamon; B Leyland-Jones; S Shak; H Fuchs; V Paton; A Bajamonde; T Fleming; W Eiermann; J Wolter; M Pegram; J Baselga; L Norton
Journal: N Engl J Med Date: 2001-03-15 Impact factor: 91.245

4. Superior in vivo efficacy of afucosylated trastuzumab in the treatment of HER2-amplified breast cancer.

Authors: Teemu T Junttila; Kathryn Parsons; Christine Olsson; Yanmei Lu; Yan Xin; Julie Theriault; Lisa Crocker; Oliver Pabonan; Tomasz Baginski; Gloria Meng; Klara Totpal; Robert F Kelley; Mark X Sliwkowski
Journal: Cancer Res Date: 2010-05-18 Impact factor: 12.701

5. Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy.

Authors: José Baselga; Karen A Gelmon; Shailendra Verma; Andrew Wardley; Pierfranco Conte; David Miles; Giulia Bianchi; Javier Cortes; Virginia A McNally; Graham A Ross; Pierre Fumoleau; Luca Gianni
Journal: J Clin Oncol Date: 2010-02-01 Impact factor: 44.544

5 in total

1 in total

1. Cancer targeted therapeutics: From molecules to drug delivery vehicles.

Authors: Daxing Liu; Debra T Auguste
Journal: J Control Release Date: 2015-09-02 Impact factor: 9.776

1 in total